Aurinia Pharmaceuticals Inc
Price
FilingsNewest: 8-K, Other eventsAug 19 →Insiders2 insiders bought $25.1M in 11 open-market buys. 1 insider sold $546,373, 0 of 2 sales on a 10b5-1 plan.→HoldersTang 9.8%BlackRock 6.2%Goldman Sachs 4.2%→PeersClosest companies: IRWD, UTHR, ZVRA→
From the filings
Figures
- Revenue
- $311.5Mlast 12 months
- Net income
- $314.1Mlast 12 months
- Operating cash flow
- $166.9Mlast 12 months
- Cash and equivalents
- $179.7Mat the last balance sheet
- Shares outstanding
- 132.9M shareson issue